Brian Piper
CIK: 0001665924
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SANA
Sana Biotechnology, Inc.
Officer
Discretionary Trading P&L
Holdings
About Piper Brian
Piper Brian (SEC CIK 0001665924) files insider reports with the SEC as EVP, Chief Financial Officer of Sana Biotechnology, Inc. (SANA).
Signal8 holds 2 ownership filings by Piper Brian (1 Form 3, 1 Form 4), filed on Feb 18, 2026. Those filings report 2 transactions, the latest on Feb 17, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Piper Brian's filings is in SEATTLE, WA.
Recent filings by Piper Brian
- Feb 17, 2026: Grants or awards of SANA derivative securities (2 lines, Form 4, code A).
Other insiders filing for Sana Biotechnology, Inc. (SANA)
- Bishop Hans Edgar, Director
- PATEL DHAVALKUMAR DHIRAJLAL, EVP, Chief Scientific Officer
- Yang Patrick Y, Director
- Rosiello Robert L., Director
- Seitz Michelle, Director
- REICIN ALISE, Director